New Age Alpha Advisors LLC bought a new stake in Exponent, Inc. (NASDAQ:EXPO – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 5,398 shares of the business services provider’s stock, valued at approximately $481,000.
Other hedge funds have also bought and sold shares of the company. Raymond James Financial Inc. bought a new position in shares of Exponent in the 4th quarter worth $55,131,000. Norges Bank purchased a new position in Exponent in the fourth quarter worth $52,381,000. JPMorgan Chase & Co. increased its stake in Exponent by 63.6% in the third quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock valued at $72,701,000 after acquiring an additional 245,086 shares during the last quarter. Geode Capital Management LLC raised its position in Exponent by 4.8% during the third quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider’s stock valued at $173,597,000 after purchasing an additional 69,099 shares in the last quarter. Finally, Vanguard Group Inc. lifted its stake in Exponent by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 5,345,503 shares of the business services provider’s stock worth $476,284,000 after purchasing an additional 67,296 shares during the last quarter. 92.37% of the stock is currently owned by institutional investors.
Insider Activity at Exponent
In other news, VP Richard Reiss sold 1,736 shares of the firm’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total transaction of $149,174.48. Following the transaction, the vice president now directly owns 1,800 shares of the company’s stock, valued at approximately $154,674. This trade represents a 49.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.10% of the stock is owned by insiders.
Exponent Trading Down 0.3 %
Exponent (NASDAQ:EXPO – Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.46 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same quarter in the previous year, the company earned $0.41 EPS. As a group, analysts predict that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.
Exponent Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also
- Five stocks we like better than Exponent
- Top Biotech Stocks: Exploring Innovation Opportunities
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- What Are Dividend Challengers?
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- How to Invest in Insurance Companies: A GuideĀ
- Buffett Trims Equities, But Still Keeps Buying This Stock
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.